Major Pharmaceutical Markets of the Middle East

Urch Publishing
February 14, 2009
89 Pages - SKU: URC2109730
Pharmaceuticals and Healthcare Report - Czech Republic - Q3 2014
7/23/2014 | published by: Business Monitor International
Czech Republic Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Pharmaceutical sales will decline further this year, following the release of poor sales datafrom the first quarter. Price declines throughout Europe and restructuring of the healthcare  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Denmark - Q3 2014
7/23/2014 | published by: Business Monitor International
Denmark Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Like many other Western European countries, Denmark's expanding elderly population willensure that demand for quality healthcare remains high and will be a key driving factor for its  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Malaysia - Q3 2014
7/23/2014 | published by: Business Monitor International
Malaysia Pharmaceuticals and Healthcare Report Q3 2014 BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality andaccess to healthcare, as the government plans to expand and upgrade its hospital network. However, wehave  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Sri Lanka - Q3 2014
7/23/2014 | published by: Business Monitor International
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notablyIndian - investors in recent years, as economic growth has picked up and the  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Cambodia and Laos Q3 2014
7/11/2014 | published by: Business Monitor International
Cambodia and Laos Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Cambodia continues to lag behind its regional peers in terms of investment in healthcareservices. As a result, we maintain that multinational pharmaceutical firms will choose  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Venezuela Q3 2014
7/11/2014 | published by: Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Price controls, high inflation, currency devaluation, import and foreign currency controls, aswell as other structurally distorting policies in Venezuela will continue to plague the country'spharmaceutical market until  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Vietnam Q3 2014
7/11/2014 | published by: Business Monitor International
Vietnam Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Extensive bureaucracy and a lack of human resources in regulatory agencies are the two keyreasons for the market barriers that innovative pharmaceutical firms face in accessing Vietnam'spharmaceutical  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Ghana
7/16/2014 | published by: Business Monitor International
Ghana Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Continuing depreciation in the Ghanaian currency has led us to revise our headline forecasts inUSD for the pharmaceutical sector downwards. In the long-term however we remain positive  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Moldova
7/16/2014 | published by: Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q3 2014 BMI View: BMI has upgraded its forecast for Moldova's pharmaceutical and healthcare market for 2014due to improved economic conditions. Moldova is likely to sign the Association Agreement with the  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Spain
7/16/2014 | published by: Business Monitor International
Spain Pharmaceuticals and Healthcare Report Q3 2014 BMI View: The weakened Spanish economy and the government's ongoing multi-faceted strategy to containexpenditure on prescription medicines by targeting patients, companies and the overall healthcare sectorpresent challenges to drugmakers  |  read more...
USD 1,295
 

SELECT A LICENSE

    Online Download  USD 2,030  
    Hard Copy Mail Delivery  USD 2,110  
    Global Site License Fulfilled by Publisher  USD 11,760  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!